These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1035 related articles for article (PubMed ID: 22712639)

  • 21. Differentiation between amnestic-mild cognitive impairment and early-stage Alzheimer's disease using the Frontal Assessment Battery test.
    Yamao A; Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kasahara H; Nakayama K
    Psychogeriatrics; 2011 Dec; 11(4):235-41. PubMed ID: 22151243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
    Papp E; Pákáski M; Drótos G; Kálmán J
    Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Saint Louis University Mental Status Examination Is Better than the Mini-Mental State Examination to Determine the Cognitive Impairment in Turkish Elderly People.
    Kaya D; Isik AT; Usarel C; Soysal P; Ellidokuz H; Grossberg GT
    J Am Med Dir Assoc; 2016 Apr; 17(4):370.e11-5. PubMed ID: 26851199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of educational background on verbal fluency task performance in older adults with Alzheimer's disease and mild cognitive impairment.
    Kawano N; Umegaki H; Suzuki Y; Yamamoto S; Mogi N; Iguchi A
    Int Psychogeriatr; 2010 Sep; 22(6):995-1002. PubMed ID: 20602860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the revised Addenbrooke's Cognitive Examination (ACE-R) for detecting mild cognitive impairment and dementia in a Japanese population.
    Yoshida H; Terada S; Honda H; Kishimoto Y; Takeda N; Oshima E; Hirayama K; Yokota O; Uchitomi Y
    Int Psychogeriatr; 2012 Jan; 24(1):28-37. PubMed ID: 21843399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reliability and validity of the mini-mental state examination in the elderly Croatian population.
    Boban M; Malojčić B; Mimica N; Vuković S; Zrilić I; Hof PR; Simić G
    Dement Geriatr Cogn Disord; 2012; 33(6):385-92. PubMed ID: 22814030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment.
    Fang R; Wang G; Huang Y; Zhuang JP; Tang HD; Wang Y; Deng YL; Xu W; Chen SD; Ren RJ
    Dement Geriatr Cogn Disord; 2014; 37(3-4):223-31. PubMed ID: 24193223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of color-form naming in Alzheimer's disease: preliminary evidence.
    Nielsen NP; Wiig EH; Warkentin S; Minthon L
    Percept Mot Skills; 2004 Dec; 99(3 Pt 2):1201-4. PubMed ID: 15739845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study.
    Dong Y; Yean Lee W; Hilal S; Saini M; Wong TY; Chen CL; Venketasubramanian N; Ikram MK
    Int Psychogeriatr; 2013 Nov; 25(11):1831-8. PubMed ID: 23870281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Decision-making and apathy in early stage of Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Bayard S; Raffard S; Gély-Nargeot MC
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):215-23. PubMed ID: 23803639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment.
    Wang T; Chen K; Li H; Dong S; Su N; Liu Y; Cheng Y; Dai J; Yang C; Xiao S
    J Clin Psychiatry; 2015 Feb; 76(2):135-41. PubMed ID: 25742200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reductions in 'Ross Information Processing Test-Geriatric' information processing and 'A Quick Test of Cognitive Speed' processing speed in Alzheimer's disease: which lead and which follow?
    Ross-Swain D; Wiig EH
    Int J Rehabil Res; 2008 Mar; 31(1):81-4. PubMed ID: 18277209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Informant Questionnaire on Cognitive Decline in the Elderly individuals in screening mild cognitive impairment with or without functional impairment.
    Li F; Jia XF; Jia J
    J Geriatr Psychiatry Neurol; 2012 Dec; 25(4):227-32. PubMed ID: 23172761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memory and Executive Screening (MES): a brief cognitive test for detecting mild cognitive impairment.
    Guo QH; Zhou B; Zhao QH; Wang B; Hong Z
    BMC Neurol; 2012 Oct; 12():119. PubMed ID: 23050770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild cognitive impairment: cognitive screening or neuropsychological assessment?
    Diniz BS; Nunes PV; Yassuda MS; Pereira FS; Flaks MK; Viola LF; Radanovic M; Abreu ID; Borelli DT; Gattaz WF; Forlenza OV
    Braz J Psychiatry; 2008 Dec; 30(4):316-21. PubMed ID: 19142405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a French version of an informant-based questionnaire as a screening test for Alzheimer's disease.
    Law S; Wolfson C
    Br J Psychiatry; 1995 Oct; 167(4):541-4. PubMed ID: 8829727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.